The first quarter of 2022 is expected to be a net profit of 95.88 million-124 million yuan, an increase of 70%-120% year-on-year, and the growth of raw plasma collection.


Full Data

?
UNLOCK DATA

Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login




Related Data